SHH and pancreatic neoplasm: Small molecule SHH inhibitor-mediated stromal depletion in a pancreatic cancer murine model administered in combination with gemcitabine produces a transient increase in tumor vascular density and an increase in the intratumoral concentration of gemcitabine, leading to transient stabilization of disease [537].